Short-course Radiation Followed by mFOLFOX-6 Plus COMPOUND 2055269 for Locally-advanced Rectal Adenocarcinoma

NCT03503630 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Rectal Cancer

Interventions

DRUG: COMPOUND 2055269
RADIATION: Radiation Therapy
DRUG: mFOLFOX
PROCEDURE: Total Mesorectal Excision

Sponsor

Ali Shamseddine

Collaborators

[object Object]
[object Object]